Answers are grounded in this paper and cite their sources.
The report highlights a significant increase in circulating vaccine-derived poliovirus outbreaks globally, predominantly type 2, emphasizing the need for prompt outbreak response with novel oral poliovirus vaccines.
(3). During this period, there were 44 cVDPV outbreaks of the three serotypes affecting 37 countries. The number of cVDPV2 cases increased from 366 in 2019 to 1,078 in 2020 (7). A goal of the Global Polio Eradication Initiative's (GPEI) 2022-2026 Strategic Plan is to better address the challenges to early CVDPV2 outbreak detection and initiate prompt and high coverage outbreak responses with available type 2 OPV to interrupt transmission by the end of 2023 (8).
No takes yet. Share an insight, caveat, or question.
Alleman et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: